Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Federico Montini, M.D.

Concepts (56)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Federico Montini's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Federico Montini has written about over time.
alpha-Synuclein, 1 publications between 2017 and 2017, average publication date June 2017. Lewy Body Disease, 1 publications between 2017 and 2017, average publication date June 2017. Pons, 1 publications between 2021 and 2021, average publication date July 2021. Steroids, 1 publications between 2021 and 2021, average publication date July 2021. Immunologic Factors, 1 publications between 2022 and 2022, average publication date January 2022. Off-Label Use, 1 publications between 2022 and 2022, average publication date January 2022. Neuromyelitis Optica, 1 publications between 2023 and 2023, average publication date January 2023. Bayes Theorem, 1 publications between 2023 and 2023, average publication date February 2023. Encephalitis, Herpes Simplex, 2 publications between 2022 and 2024, average publication date February 2023. Multiple Sclerosis, 8 publications between 2021 and 2024, average publication date April 2023. Autoimmunity, 1 publications between 2023 and 2023, average publication date May 2023. Hepatocyte Nuclear Factor 4, 1 publications between 2023 and 2023, average publication date May 2023. RNA, Viral, 1 publications between 2024 and 2024, average publication date March 2024. Amyotrophic Lateral Sclerosis, 1 publications between 2024 and 2024, average publication date July 2024.

To see the data from this visualization as text, click here.
Montini's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (56)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.